HAV VACCINES LIMITED
ActiveKey figures
Like most small UK companies, HAV VACCINES LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Sector comparison
SIC 21200Where the company stands among the 519 active companies whose first SIC code is 21200 (Manufacture of pharmaceutical preparations).
- GLAXO OPERATIONS UK LIMITED£1.1bn
- JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED£465.3m
- TEVA PHARMA HOLDINGS LIMITED£369.8m
- NAPP PHARMACEUTICAL HOLDINGS LIMITED£322.1m
- ACTAVIS HOLDINGS UK II LIMITED£278.8m
- CURIA GLOBAL HOLDINGS LIMITED£204.6m
- TEVA UK LIMITED£191.5m
- CATALENT CTS (EDINBURGH) LIMITED£162m
- NAPP PHARMACEUTICAL GROUP LIMITED£135.3m
- TEVA NI LIMITED£114.3m
Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 519. The line on each bar marks the median.
Summary: HAV VACCINES LIMITED
What kind of company is it?
HAV VACCINES LIMITED is a private limited company registered with Companies House under company number 06962730. It was incorporated on 15 Jul 2009. Its status is active. The registered office is in Newport pagnell (MK16). Its nature of business (SIC 2007) is manufacture of pharmaceutical preparations (21200).
How is the company doing financially?
The latest accounts in the database are for 2024/25 (period ending 31 Jul 2025); the company files micro-entity accounts. Net assets were £213,824, up 71.4% on the previous year. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).
How does it compare with similar companies?
Compared with 519 active companies whose first SIC code is 21200: By net assets it ranks higher than 59% of them (median £65,124). By total assets it ranks lower than 55% of them (median £318,403). By number of employees it ranks lower than 65% of them (median 2). It is older than 72% of them (median age 8.2 years).
Who runs and controls the company?
The company has 2 current directors. One person with significant control is registered.
When are its next filings due?
The next accounts are due by 30 Apr 2027. The next confirmation statement is due by 24 Jul 2027.
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Total assets | 653,373 | 490,344 | 358,952 | 129,289 | 214,038 |
| Total liabilities | 7,975 | 20,689 | 1,943 | — | — |
| Net assets / total equity | 643,798 | 468,155 | 357,009 | 124,752 | 213,824 |
| Average number of employees | 0 | 0 | 0 | 0 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
History
16 events- Financial year 2024/25 endedAccounts: net assets £213.8k, 0 employees
- Financial year 2023/24 endedAccounts: net assets £124.8k, 0 employees
- Financial year 2022/23 endedAccounts: net assets £357k, 0 employees
- Financial year 2021/22 endedAccounts: net assets £468.2k, 0 employees
- John HERMON-TAYLOR resignedDirector
- Professor John Hermon-Taylor ceased to be a person with significant control
- Financial year 2020/21 endedAccounts: net assets £643.8k, 0 employees
- Financial year 2019/20 endedAccounts: net assets £852.9k, 0 employees
Earlier events (8)
- Mr Michael Thomas Gwynfor Paynter registered as a person with significant control
- Professor John Hermon-Taylor registered as a person with significant control
- Allan Charles CAMBRIDGE resignedDirector
- Michael James Dahl STALLIBRASS appointedDirector
- Allan Charles CAMBRIDGE appointedDirector
- John HERMON-TAYLOR appointedDirector
- Michael Thomas Gwynfor PAYNTER appointedDirector
- Company incorporatedPrivate limited company
Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current and former persons with significant control, and the end of each financial year with figures in the database.